MaxLinear
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 3 Sell calls were followed by a 15% average decline over the next quarter.
- Recent price momentum is +90.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 5.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 21.5x | Better than 32% |
| Price / Sales | 7.7x | Better than 14% |
Growth F
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -25.3% | Better than 2% |
| Free cash flow CAGR (3Y) | -26.1% | Better than 14% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 56.8% | Better than 71% |
| Operating margin | -21.9% | Better than 12% |
| Net margin | -29.2% | Better than 11% |
| Return on equity | -28.2% | Better than 13% |
| Return on invested capital | -20.6% | Better than 13% |
Momentum C-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -37.8% | Better than 12% |
| 6-month return | -58.2% | Better than 5% |
| 12-month return (ex latest month) | 366.6% | Better than 100% |
| Distance below 52-week high | 67.7% | Better than 7% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.3x | Better than 35% |
| Debt to assets | 18.2% | Better than 58% |
| Interest coverage | -13.0x | Better than 12% |
| Free cash flow / net income | 268.9% | Better than 84% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 33.3% | Better than 15% |
| Upside to average target | 117.1% | Better than 87% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 48.13
- Open
- 45.70
- Day range
- 40.93 - 46.48
- Avg price
- 42.64
- Volume
- 2.81M
- Turnover
- 119.68M
- Turnover ratei
- 3.28%
- Volume ratioi
- 1.22
- Amplitudei
- 11.53%
- 52-week rangei
- 14.27 - 128.30
Valuation
- P/Ei
- -26.23
- P/E (TTM)i
- -125.61
- P/Bi
- 7.08
- EPSi
- -1.58
- Book value / shi
- 5.86
- Net profit
- -143.78M
- Net assets
- 532.99M
Share structure
- Market cap
- 3.77B
- Float capi
- 3.55B
- Shares out
- 91.00M
- Float sharesi
- 85.53M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
67.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-7.78M net over the window
Short interest
- Shares short
- 4.62M
- % of floati
- 5.07%
- Days to coveri
- 1.22
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of MaxLinear (MXL)?
MaxLinear last traded at 41.45. This page shows a periodic quote snapshot. Check the displayed quote time.
What is MaxLinear's market cap?
About 3.77B.
What is the P/E ratio of MaxLinear?
The trailing twelve-month P/E is -125.61. The Valuation tab shows it against the stock's own five-year range.
Does MaxLinear pay a dividend?
MaxLinear does not currently pay a regular dividend.
Is MaxLinear a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 90.00, which implies 117.1% upside from the current price. This is not investment advice.
What is MaxLinear's StockVane Quant Rating?
The StockVane Momentum strategy currently rates MaxLinear a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.
MaxLinear discussion 0 comments